FI67706C - Foerfarande foer framstaellning av terapeutiskt anvaendbara n-5-tetrazolyl)-1-oxo-1h-tiazolo(3,2-a)pyrimidin-2-karboxyl atr - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara n-5-tetrazolyl)-1-oxo-1h-tiazolo(3,2-a)pyrimidin-2-karboxyl atr Download PDF

Info

Publication number
FI67706C
FI67706C FI803628A FI803628A FI67706C FI 67706 C FI67706 C FI 67706C FI 803628 A FI803628 A FI 803628A FI 803628 A FI803628 A FI 803628A FI 67706 C FI67706 C FI 67706C
Authority
FI
Finland
Prior art keywords
oxo
pyrimidine
mmol
ethyl
preparation
Prior art date
Application number
FI803628A
Other languages
English (en)
Finnish (fi)
Other versions
FI803628L (fi
FI67706B (fi
Inventor
Saul Bernard Kadin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI803628L publication Critical patent/FI803628L/fi
Priority to FI842396A priority Critical patent/FI71158C/fi
Application granted granted Critical
Publication of FI67706B publication Critical patent/FI67706B/fi
Publication of FI67706C publication Critical patent/FI67706C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FI803628A 1979-11-23 1980-11-21 Foerfarande foer framstaellning av terapeutiskt anvaendbara n-5-tetrazolyl)-1-oxo-1h-tiazolo(3,2-a)pyrimidin-2-karboxyl atr FI67706C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI842396A FI71158C (fi) 1979-11-23 1984-06-13 Foerfarande foer framstaellning av terapeutiskt anvaendbara 1-xo-1h-tiazolo/3,2-a/pyrimidin-2-karboxylsyror

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9663179A 1979-11-23 1979-11-23
US9663179 1979-11-23

Publications (3)

Publication Number Publication Date
FI803628L FI803628L (fi) 1981-05-24
FI67706B FI67706B (fi) 1985-01-31
FI67706C true FI67706C (fi) 1985-05-10

Family

ID=22258306

Family Applications (1)

Application Number Title Priority Date Filing Date
FI803628A FI67706C (fi) 1979-11-23 1980-11-21 Foerfarande foer framstaellning av terapeutiskt anvaendbara n-5-tetrazolyl)-1-oxo-1h-tiazolo(3,2-a)pyrimidin-2-karboxyl atr

Country Status (35)

Country Link
JP (1) JPS5687586A (ru)
KR (1) KR830004322A (ru)
AR (2) AR228859A1 (ru)
AT (1) AT380883B (ru)
AU (1) AU520995B2 (ru)
BE (1) BE886319A (ru)
CA (1) CA1143731A (ru)
CH (1) CH649299A5 (ru)
CS (1) CS241476B2 (ru)
DD (1) DD154608A5 (ru)
DE (2) DE3043979C2 (ru)
DK (1) DK151811C (ru)
EG (1) EG14929A (ru)
ES (1) ES8203363A1 (ru)
FI (1) FI67706C (ru)
FR (1) FR2470132A1 (ru)
GB (1) GB2063862B (ru)
GR (1) GR72132B (ru)
GT (1) GT198066458A (ru)
HU (1) HU179091B (ru)
IE (1) IE50404B1 (ru)
IL (1) IL61535A (ru)
IN (1) IN154926B (ru)
IT (1) IT1209373B (ru)
LU (1) LU82950A1 (ru)
NL (1) NL182565C (ru)
NO (1) NO803521L (ru)
NZ (1) NZ195596A (ru)
PH (1) PH16666A (ru)
PL (1) PL132354B1 (ru)
PT (1) PT72090B (ru)
SE (1) SE448732B (ru)
SU (1) SU1042620A3 (ru)
YU (1) YU41953B (ru)
ZA (1) ZA807293B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8300728D0 (en) * 1983-01-12 1983-02-16 Erba Farmitalia Substituted carboxy-thiazolo / 3 2 - a / pyrimidine derivatives
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
GB8422916D0 (en) * 1984-09-11 1984-10-17 May & Baker Ltd Compositions of matter
JP2690742B2 (ja) * 1987-03-30 1997-12-17 第一製薬株式会社 複素環アミン誘導体
NZ228447A (en) * 1988-03-28 1990-08-28 Janssen Pharmaceutica Nv Cosmetic or pharmaceutical composition possessing serotonin antogonistic activity
TWI500623B (zh) * 2009-10-13 2015-09-21 Torrent Pharmaceuticals Ltd 新穎稠合噻唑及噁唑嘧啶酮

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1331059A (en) * 1971-04-19 1973-09-19 Lilly Industries Ltd Pyrimidotriazinone compounds
US4041163A (en) * 1976-03-29 1977-08-09 Pfizer Inc. N-(5-Tetrazolyl)-4-oxo-4H-pyrimido(2,1-b)benzothiazole-3-carboxamide antiallergy agents
DE2810863A1 (de) * 1978-03-13 1979-09-27 Boehringer Mannheim Gmbh 1-oxo-1h-pyrimido eckige klammer auf 6,1-b eckige klammer zu benzthiazol-derivate und verfahren zu ihrer herstellung
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones

Also Published As

Publication number Publication date
IL61535A0 (en) 1980-12-31
LU82950A1 (fr) 1981-06-04
AR231296A1 (es) 1984-10-31
FR2470132B1 (ru) 1983-07-29
DK151811C (da) 1988-06-06
FI803628L (fi) 1981-05-24
HU179091B (en) 1982-08-28
SE8008189L (sv) 1981-05-24
PT72090A (en) 1980-12-01
CS782080A2 (en) 1985-06-13
YU41953B (en) 1988-02-29
DE3050491C2 (de) 1985-10-10
NZ195596A (en) 1984-05-31
PL132354B1 (en) 1985-02-28
AU520995B2 (en) 1982-03-11
PT72090B (en) 1981-09-29
CS241476B2 (en) 1986-03-13
FR2470132A1 (fr) 1981-05-29
YU295080A (en) 1983-06-30
IE50404B1 (en) 1986-04-16
IT8026176A0 (it) 1980-11-21
EG14929A (en) 1989-01-30
GB2063862A (en) 1981-06-10
NL8006362A (nl) 1981-06-16
GT198066458A (es) 1982-05-15
NL182565B (nl) 1987-11-02
JPS617432B2 (ru) 1986-03-06
FI67706B (fi) 1985-01-31
DK413180A (da) 1981-05-24
SU1042620A3 (ru) 1983-09-15
CH649299A5 (fr) 1985-05-15
ES497066A0 (es) 1982-04-01
CA1143731A (en) 1983-03-29
DE3043979C2 (de) 1986-08-21
GB2063862B (en) 1983-06-22
SE448732B (sv) 1987-03-16
IT1209373B (it) 1989-07-16
PL228008A1 (ru) 1981-12-11
IN154926B (ru) 1984-12-22
AR228859A1 (es) 1983-04-29
JPS5687586A (en) 1981-07-16
AU6459580A (en) 1981-05-28
GR72132B (ru) 1983-09-19
ATA570780A (de) 1985-12-15
PH16666A (en) 1983-12-13
IL61535A (en) 1984-06-29
DD154608A5 (de) 1982-04-07
AT380883B (de) 1986-07-25
ES8203363A1 (es) 1982-04-01
DK151811B (da) 1988-01-04
DE3043979A1 (de) 1981-09-03
NO803521L (no) 1981-05-25
BE886319A (fr) 1981-05-25
IE802418L (en) 1981-05-23
ZA807293B (en) 1981-12-30
KR830004322A (ko) 1983-07-09
NL182565C (nl) 1988-04-05

Similar Documents

Publication Publication Date Title
KR850001795B1 (ko) 2,4-이치환된 티아졸 유도체의 제조방법
US4174397A (en) Thiazolidine derivatives
HU188852B (en) Process for producing thiazolidine derivatives active against gastric ulcer and intestinal ulcer
DE2740588A1 (de) Imidazo- eckige klammer auf 1,2-a eckige klammer zu -chinolin-2-carbon- saeuren und deren derivate sowie pharmazeutische zubereitungen, die diese verbindungen enthalten
US4041163A (en) N-(5-Tetrazolyl)-4-oxo-4H-pyrimido(2,1-b)benzothiazole-3-carboxamide antiallergy agents
US4734413A (en) Substituted 1,2,4-triazolo[1,5-A]triazines as bronchodilators
FI67706C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara n-5-tetrazolyl)-1-oxo-1h-tiazolo(3,2-a)pyrimidin-2-karboxyl atr
US3798226A (en) 3-acylamino-4-phenylquinolines carrying a substituent on the benzene ring
US4064260A (en) Anti-inflammatory diarylimidazothiazoles and their corresponding S-oxides
AU596869B2 (en) 2-(thio-linked)-pyridine-5-(4,5-dihydro-2-oxazolyl)-(thieno( 2,3-d)-imidazoles and -benzimidazoles), a process for their preparation, and their use
US4423048A (en) Antiallergic and antiulcer 1-oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides and intermediates therefor
US4535081A (en) Antiallergic and antiulcer 1-oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides and intermediates therefor
JPH0667919B2 (ja) 新規なインデノチアゾ−ル誘導体及びその製造法
NO824331L (no) Fremgangsmaate ved fremstilling av 2-fenylimidazo(2,1-b)benzothiazolforbindelser
US4414388A (en) 1-Oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides
US4965266A (en) Heteroarylcarboxamide derivatives, process for preparing the same and pharmaceutical composition containing the same
KR820002280B1 (ko) 벤즈 이미다졸의 제조방법
FI71158B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1-xo-1h-tiazolo/3,2-a/pyrimidin-2-karboxylsyror
CA1051891A (en) Triazolocycloalkylthiadiazine derivatives
RU2090559C1 (ru) Рацемические или оптически активные производные изохинолина, способ их получения, фармацевтическая композиция на их основе и способ получения фармацевтической композиции
NL8400099A (nl) Gesubstitueerde carboxy-thiazolo3,2-apyrimidinederivaten, werkwijze ter bereiding daarvan en farmaceutische samenstellingen, die deze derivaten bevatten.
EP0279298B1 (en) Tricyclic triazolopyrimidine derivatives
EP0284018B1 (en) Benzopyran[4,3-d]-thiazole-derivatives with anti-allergic, anti-anaphylactic and anti-arthritic activity and compositions containing them
US4761474A (en) 3-(1H-tetrazol-5-yl)thieno[2,3-d]pyrimidin-4(3H)-ones
KR790001315B1 (ko) N-테트라졸릴-1-옥소-1H-6-(R₃-치환) 피리미도[1,2-a] 퀴놀린-2-카복스아미드류의 제조방법.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: PFIZER INC.